Emily Pimblett, CHIEF ACCOUNTING OFFICER at Eliem Therapeutics, Inc. (ELYM), sold 1,191 shares at $8.06 ($10K) on 2024-09-20, disclosed to the SEC on 2024-09-20.
Scheduled sale ($10k) by CHIEF ACCOUNTING OFFICER under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $8.06 | 9 | $73 | 0.7% |
| 2 | $8.18 | 1,182 | $10K | 99.3% |
| Total | $8.18 avg | 1,191 | $10K | 100% |
| Filing → |
| CLYM | SELL | 2024-12-20 | $2K | — | Filing → |
| ELYM | SELL | 2024-06-21 | $9K | — | Filing → |